A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies

GA Cirkel, B M Kerklaan, F Vanhoutte, A Van der Aa, G Lorenzon, F Namour, P Pujuguet, S Darquenne, FYF de Vos, TJ Snijders, EE Voest, JHM Schellens, Martijn Lolkema

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)184-192
Number of pages9
JournalInvestigational New Drugs
Issue number2
Publication statusPublished - 2016

Cite this